FDA Commissioner nominee Scott Gottlieb says the OTC monograph program, a system the agency is looking at modernizing, needed “immediate action” 10 years ago before he left a commissioner’s office post.
Gottlieb was asked only one question about nonprescription drugs regulation during his confirmation hearing before the Senate Health, Education, Labor and Pensions Committee on April 5, but it covered
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?